BNP Paribas Fortis

Eastern Steel Sdn Bhd, incorporated in 2001, is a steel manufacturing company located in Kemaman, Terengganu, Malaysia. The company operates steel mills and specializes in various steel products. As of May 2010, it functions as a subsidiary of Shanxi JianLong Industry Company Limited. Eastern Steel plays a significant role in the local steel industry, contributing to the region's manufacturing capabilities.

Stûv is a designer and manufacturer specializing in wood-burning appliances for residential use. The company produces a range of products, including wood stoves, pellet stoves, and fireplace inserts, aimed at enhancing home heating solutions. With a focus on quality and design, Stûv combines functionality with aesthetics to meet the needs of modern households.

Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.

MobieTrain is a performance enablement platform that focuses on mobile microlearning for frontline teams. It allows organizations to create customized learning tracks using their own training content, thereby facilitating skill acquisition for employees in various companies, including Emirates Post, Decathlon, and Timberland. The platform enhances knowledge transfer effectiveness by six times and significantly reduces content creation and administration time, streamlining processes in onboarding, employee engagement, sales, compliance, and change management. MobieTrain's mobile-first approach delivers daily, bite-sized learning content that is gamified and personalized, improving knowledge retention and productivity. By making learning accessible on any mobile device, MobieTrain aims to transform employee development into an engaging experience.

Aircastle Limited, founded in 2004 and based in Stamford, Connecticut, specializes in the acquisition, leasing, financing, and management of commercial flight equipment for airlines globally. The company operates a portfolio that includes modern, operationally efficient jets, which it leases to a diverse customer base. As of 2019, Aircastle's fleet comprised 287 aircraft leased to 85 lessees across 49 countries. The company's focus on high-utility commercial jets enables it to serve a wide range of airline customers, enhancing its presence in the aviation sector. In March 2020, Aircastle became a subsidiary of Marubeni Corporation, further integrating its operations within a larger corporate structure.

Castore has been created to bring a new level of performance to men’s sportswear. They are the world’s first premium sportswear brand specifically for men, targeting only the most discerning athletes who value the attention to detail and precision performance features that underpin all garments. The Castore brand DNA lies in an unrelenting focus on technical innovation to create the most advanced products for those individuals who simply cannot settle for second best.

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door.

Abbove develops a collaborative wealth planning platform for financial advisors that want to serve their clients with a structured and holistic approach to their wealth. To that end, the solution supports advisors' wealth management activities on three levels: to completely understand their clients' (wealth) situation by providing detailed inventories to store and organise wealth data, to serve their clients with the right advice at the right time with the help of planning and simulation tools (such as a financial planning simulator, inheritance tax calculator and reporting tool) connected to the clients' latest wealth data and to offer their clients continuous support and a unique experience through an intuitive interface that's accessible 24/7 to both advisors, their clients and other trusted third parties.

Xenomatix specializes in solid-state light detection and ranging solutions that cater to advanced driver assistance systems (ADAS) and autonomous driving technologies. The company develops automotive vision systems utilizing laser-based technology and complementary metal oxide semiconductor detectors, enabling real-time 3D digitization of vehicle surroundings. Their products are also applicable in various sectors, including road construction, surveying, industrial, automotive, mining, agriculture, off-road activities, and railway operations. By providing innovative solutions, Xenomatix helps enhance safety and efficiency in both automotive and industrial markets.

Dockflow operates a blockchain-based platform designed to enhance the efficiency and experience of logistics teams. By providing tools for maritime container shipment visibility, tracking, and sensitive cargo monitoring, Dockflow streamlines operations and reduces the burden of manual checks and data management. The platform also facilitates collaboration among logistics professionals, allowing them to focus on delivering better service to customers and engaging in more meaningful tasks. Overall, Dockflow aims to transform logistics operations by automating routine processes and improving communication within the industry.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

MobieTrain is a performance enablement platform that focuses on mobile microlearning for frontline teams. It allows organizations to create customized learning tracks using their own training content, thereby facilitating skill acquisition for employees in various companies, including Emirates Post, Decathlon, and Timberland. The platform enhances knowledge transfer effectiveness by six times and significantly reduces content creation and administration time, streamlining processes in onboarding, employee engagement, sales, compliance, and change management. MobieTrain's mobile-first approach delivers daily, bite-sized learning content that is gamified and personalized, improving knowledge retention and productivity. By making learning accessible on any mobile device, MobieTrain aims to transform employee development into an engaging experience.

Dockflow operates a blockchain-based platform designed to enhance the efficiency and experience of logistics teams. By providing tools for maritime container shipment visibility, tracking, and sensitive cargo monitoring, Dockflow streamlines operations and reduces the burden of manual checks and data management. The platform also facilitates collaboration among logistics professionals, allowing them to focus on delivering better service to customers and engaging in more meaningful tasks. Overall, Dockflow aims to transform logistics operations by automating routine processes and improving communication within the industry.

SIRO Network is constructed utilizing the overhead and subsurface ESB infrastructure, guaranteeing an efficient, stable, and lengthy network. By deploying optical fiber that enters a home, building, or business directly, is an access network technology that provides the fastest Internet connection imaginable. All constraints that hinder the efficiency of other types of networks are eliminated.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for Alzheimer’s, Parkinson’s, diabetes, and other protein-misfolding disorders. The company is advancing several investigational compounds, including ReS19-T for Alzheimer’s and ReS39 for diabetes, as well as ReS3-T, which targets neuronal hyperactivity associated with Alzheimer’s and epilepsy. Additionally, reMYND operates a phenotypic screening platform aimed at discovering small molecule treatments that mitigate the toxicity of misfolded proteins such as Tau and Synuclein. The company also functions as a contract research organization (CRO), providing services that assess the in-vivo characteristics and effects of experimental therapies using proprietary mouse models. This CRO capability has enabled reMYND to support various pharmaceutical clients, including major companies in the United States, Europe, and Japan, by delivering critical proof-of-concept data for drugs in clinical development. Established in 2002, reMYND is committed to addressing the challenges posed by protein misfolding diseases through innovative research and development.

Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. The company holds a unique position on the market thanks to having all its laboratories on one site, 150 highly qualified professionals and over 30 years’ expertise at the forefront of analytical sciences.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.